Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Arrowhead Pharmaceuticals, Inc.

NASDAQ: ARWR · Life Sciences · 3 alerts · CIK 879407

Share price
$44.21Close, Nov 16
Market cap
$6.25B
Shares outstanding
141.37MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Arrowhead Pharmaceuticals, Inc. filings on SEC EDGAR ↗

7:30 AM ET 8-K
Loan & Debt

Arrowhead Pharmaceuticals $400M Debt Financing with Sixth Street Lending Partners

Arrowhead Pharmaceuticals refinanced its existing senior secured term loans by entering into a new $400 million Amended and Restated Financing Agreement with Sixth Street. The new facility significantly lowers borrowing costs from a 15% fixed rate to SOFR plus 5.50%, extends the maturity to November 2031, and eliminates previous requirements to sweep commercial revenue or milestone payments for debt repayment.

Value
$400M
Counterparty
Sixth Street Lending Partners
Term
5 years

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.